High levels of pantetheine 4′-phosphate may lead to lipid metabolic disorder characterized by an increase in the synthesis of fatty acid synthase, which may promote NAFLD development or NASH progression (28). Here, FASN is linked to metabolic dysfunction-associated steatotic liver disease.